Thus, chromium 2 plays a role in the metabolism of macronutrients and contributes to maintaining normal blood glucose levels
Vanuytsel et al., 2021)
Figure 2 5 Clinical research progress and safety evaluation 5.1 Clinical efficacy studies Tirzepatide, a novel dual GLP-1 and GIP receptor agonist, has demonstrated remarkable efficacy in the management of type 2 diabetes and obesity, as evidenced by multiple high-quality clinical trials (43, 44)
The researchers argued, The increased risk associated with short-acting analogs needs further studies to validate these findings. The possible protective effect of GLP-1 receptor agonists against AMD may be primarily attributed to their ability to mitigate chronic retinal inflammation and oxidative stress, which are pivotal in the pathogenesis of AMD, the authors explained in their paper
Erste Vernderungen wie eine ruhigere Haut oder ein dichter wirkender Wimpernkranz zeigen sich oft nach vier bis acht Wochen
Weight loss varies depending on genetics, adherence, physical activity, nutrition, and medical conditions
